Drug Profile
Dextropropoxyphene/paracetamol - Xanodyne
Alternative Names: Propoxyphene/acetaminophen - Xanodyne; XP 20BLatest Information Update: 16 Nov 2017
Price :
$50
*
At a glance
- Originator AAIPharma
- Developer Xanodyne Pharmaceuticals
- Class Acetanilides; Antipyretics; Non-opioid analgesics; Opioid analgesics; Propionates; Small molecules
- Mechanism of Action Opioid receptor agonists; Prostaglandin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Acute pain
Most Recent Events
- 31 Dec 2010 No development reported - Phase-III for Acute pain in USA (PO)
- 28 May 2008 Phase-III clinical trials for Acute pain in USA (PO)